92 related articles for article (PubMed ID: 20361943)
1. Obaculactone suppresses Th1 effector cell function through down-regulation of T-bet and prolongs skin graft survival in mice.
Gong F; Shen Y; Zhang Q; Sun Y; Tang J; Tao F; Xu Q
Biochem Pharmacol; 2010 Jul; 80(2):218-25. PubMed ID: 20361943
[TBL] [Abstract][Full Text] [Related]
2. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.
Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W
Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive effects of an ethyl acetate extract from Urtica dentata Hand on skin allograft rejection.
Xiang M; Hou WR; Xie SN; Zhang WD; Wang X
J Ethnopharmacol; 2009 Oct; 126(1):57-63. PubMed ID: 19698774
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
5. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
7. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
9. The role of Foxp3+ regulatory T cells in liver transplant tolerance.
Li W; Carper K; Zheng XX; Kuhr CS; Reyes JD; Liang Y; Perkins DL; Thomson AW; Perkins JD
Transplant Proc; 2006 Dec; 38(10):3205-6. PubMed ID: 17175223
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
11. Determination of the functional status of alloreactive T cells by interferon-gamma kinetics.
Kwun J; Knechtle SJ; Hu H
Transplantation; 2006 Feb; 81(4):590-8. PubMed ID: 16495808
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.
Bruinsma M; van Soest PL; Leenen PJ; Löwenberg B; Cornelissen JJ; Braakman E
J Immunol; 2009 Jun; 182(12):7364-9. PubMed ID: 19494258
[TBL] [Abstract][Full Text] [Related]
13. Icaritin inhibits T cell activation and prolongs skin allograft survival in mice.
Li X; Hu Y; He L; Wang S; Zhou H; Liu S
Int Immunopharmacol; 2012 May; 13(1):1-7. PubMed ID: 22406176
[TBL] [Abstract][Full Text] [Related]
14. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice.
Fu BM; He XS; Yu S; Hu AB; Zhang J; Ma Y; Tam NL; Huang JF
Cell Immunol; 2010; 261(1):69-76. PubMed ID: 20038461
[TBL] [Abstract][Full Text] [Related]
15. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
16. Effect of in vitroexpanded CD4(+)CD25(+)Foxp3(+) regulatory T cell therapy combined with lymphodepletion in murine skin allotransplantation.
Park YH; Koo SK; Kim Y; Kim HM; Joe IY; Park CS; Kim SC; Han DJ; Lim DG
Clin Immunol; 2010 Apr; 135(1):43-54. PubMed ID: 20006940
[TBL] [Abstract][Full Text] [Related]
17. Tehranolide could shift the immune response towards Th1 and modulate the intra-tumor infiltrated T regulatory cells.
Noori S; Taghikhani M; Hassan ZM; Allameh A; Mostafaei A
Iran J Immunol; 2009 Dec; 6(4):216-24. PubMed ID: 20054110
[TBL] [Abstract][Full Text] [Related]
18. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
[TBL] [Abstract][Full Text] [Related]
19. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
